Latest News & Features
Europe
With the US Supreme Court set to decide the biosimilars dispute between Amgen and Sandoz, LSIPR examines the possible outcomes and implications for those in the industry. 21 June 2017
Americas
The perceived problem with 35 USC section 101 is a “fundamental question of national innovation policy”, claimed Kevin Rhodes, vice president and chief IP counsel at multinational conglomerate 3M. 21 June 2017
Americas
“I will think about this every day until the day I die … whether there was something more we could have done to have won the [Brexit] referendum,” said former UK Prime Minister David Cameron. 21 June 2017
Medtech
A handful of high-profile disputes over medical use patents have been decided in Japan, as Osamu Yamamoto of Yuasa and Hara reports. 21 June 2017
Africa
The creator of OmniRat, the first human monoclonal antibody technology based on rats, outlined the success story of the project yesterday at the 2017 BIO International Convention. 20 June 2017
Americas
The biopharma industry must do its part in changing the public's view of the sector, because the political reality is that it is unpopular, according to Brent Saunders, chairman, president and CEO of Allergan. 20 June 2017
Americas
Pharmaceutical company Orexo has filed a complaint against Actavis Elizabeth and Teva Pharmaceuticals for infringing its patents covering Zubsolv. 20 June 2017
Asia
Genome editing company Intellia Therapeutics has been granted a patent from China’s State Intellectual Property Office covering the CRISPR/Cas9 technology. 20 June 2017
Big Pharma
The EU’s General Court will this month hear three competition cases involving generic companies, with the first—brought by Slovenian business Krka—being heard today. 20 June 2017
Americas
The US Court of Appeals for the Federal Circuit has affirmed a district court’s ruling in a dispute over diagnostic tests for cardiovascular diseases. 19 June 2017